The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Achieving B-Cell Lymphoma Growth Modulation and Enhanced Tumor Resistance Using Idiotype/Cytokine Conjugates

Cancer treatments aimed at mobilizing host immunity must not only identify tumor antigens but improve the efficacy of antigen presentation. Researchers at Stanford recognized the importance of local cytokine action in increasing antigen presentation. This...
more information »

Methods and Technologies for Combatting Resistance to the Anti-Cancer Drug Taxane and Its Derivatives

Researchers in the lab of Dr. Stanley Cohen have developed methods to identify genes that diminish the sensitivity of tumor cells to chemotherapeutic agents and to manipulate these proteins as to make tumor cells more sensitive to them. Specifically, the...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.